Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company names an interim CEO and ...

At Kenvue, we learn, test, partner and optimize to bring real solutions into communities, homes and consumers’ hands. Using cutting-edge science and technology, we work diligently to earn people’s ...

Kenvue has outpaced the broader market over the past year, and analysts remain cautiously optimistic about the stock’s ...

U.S. stocks retreated in the final session of an otherwise solid July as traders remained apprehensive ahead of President ...

Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

Kenvue's board has nudged up its quarterly dividend by 1.2%, to 20.75 cents from 20.5 cents, extending the consumer-health company's royal payout status. The new quarterly rate, equal to 83 cents a ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company.

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson ...

Kenvue Inc. closed 11.16% below its 52-week high of $25.17, which the company achieved on May 8th.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.